BIOMARIN PHARMACEUTICAL INC Other Current Assets
BIOMARIN PHARMACEUTICAL INC (BMRN) had Other Current Assets of $254.05 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Current $254.05M.
- 2026-03-31: Other Assets, Current $205.50M.
- 2025-12-31: Other Assets, Current $185.78M.
- 2025-09-30: Other Assets, Current $204.26M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $254.05M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $205.50M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $185.78M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $204.26M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $177.18M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $181.54M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $201.53M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $169.26M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $160.43M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $163.29M 10-Q · filed 2024-04-26 | |
| 2023-12-31 | $141.39M 10-K · filed 2025-02-24 | |
| 2023-09-30 | $224.81M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $193.39M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $173.18M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $104.52M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $149.85M 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $139.03M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $121.28M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $110.44M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $107.75M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $99.05M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $91.25M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $129.93M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $120.75M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $142.13M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $155.82M 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $130.66M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $126.55M 10-Q/A · filed 2019-11-04 | |
| 2019-06-30 | $119.78M 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $93.88M 10-Q · filed 2019-04-29 | |
| 2018-12-31 | $98.40M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $71.65M 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $80.07M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $71.76M 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $74.04M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $83.65M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $62.88M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $60.34M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $61.71M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $68.41M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $61.95M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $58.21M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $60.38M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $115.33M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $77.56M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $84.27M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $108.52M 10-K · filed 2016-02-29 | $105.31M 10-K · filed 2015-03-02 |
| 2014-09-30 | $56.46M 10-Q · filed 2014-10-28 | |
| 2014-06-30 | $37.27M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $41.01M 10-Q · filed 2014-05-02 | |
| 2013-12-31 | $41.71M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $28.16M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $33.53M 10-Q · filed 2013-07-29 | |
| 2013-03-31 | $35.50M 10-Q · filed 2013-04-29 | |
| 2012-12-31 | $25.51M 10-K · filed 2014-02-26 | |
| 2012-09-30 | $54.82M 10-Q · filed 2012-10-29 | |
| 2012-06-30 | $58.07M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $50.52M 10-Q · filed 2012-04-30 | |
| 2011-12-31 | $18.64M 10-K · filed 2013-02-26 | $39.75M 10-K · filed 2012-02-22 |
| 2011-09-30 | $39.97M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $36.29M 10-Q · filed 2011-08-01 | |
| 2011-03-31 | $34.98M 10-Q · filed 2011-04-29 | |
| 2010-12-31 | $33.87M 10-K · filed 2012-02-22 | |
| 2010-09-30 | $31.75M 10-Q · filed 2010-10-29 | |
| 2010-06-30 | $22.77M 10-Q · filed 2010-08-04 | |
| 2009-12-31 | $14.85M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |